Amazon is being threatened with legal action from the US medicines watchdog over the sales of “unapproved” drugs on its online site, as the tech giant faces scrutiny while seeking to break further into the $4tn American healthcare industry.
Read the full article on the Financial Times website
NAM Implications:
- Healthcare is too important to Amazon to risk alienating the regulators.
- Therefore, they will react positively to any slap on the wrist moves by the FDA.
- Knowing that they (Amazon) can bring so much to the consumer-facing healthcare party…
- …they simply have to work forward slowly but surely.
- (Meanwhile, suppliers should climb aboard now while this pace is manageable)
